Scheduled to present at 3 p.m. based on updated agenda
NEWARK, Del., Aug. 22 /PRNewswire-FirstCall/ -- Strategic Diagnostics Inc. (Nasdaq: SDIX) -- a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, environmental and life science applications, announced today that due to a change in the conference agenda, SDI's presentation at the Roth Capital Partner's Roth 2007 New York Conference at the Westin Hotel in Manhattan is now scheduled for 3 p.m. on Sept 5, 2007 in the Majestic II (Track 1) room.
The presentation will be webcast at http://www.wsw.com/webcast/roth13/sdix/ for approximately 30 days following the conclusion of the presentation. Following the presentation, Mr. Knight will attend a breakout session. One-on-one meetings may be scheduled through Roth Capital Partners by calling (949) 720-5700.
Each presentation is designed to provide analysts, institutional
brokers and portfolio managers with an overview of the Company's expertise
in the production of antibodies, used both in diagnostic tests and provided
to the proteomics, pharmaceutical, diagnostics and biomedical research
industries to enable rapid discovery and commercialization of products.
Strategic Diagnostics is a leader in the food pathogen industry, providing
comprehensive, accurate, and easy-to-use tests including the recently
introduced RapidChek(R) SELECT(TM) Salmonella product. The Company is also
an emerging leader in producing monoclonal and polyclonal antibodies for
the pharmaceutical and research industries. The Company's patent-pending
technology also addresses renewable energy opportunities a
|SOURCE Strategic Diagnostics Inc.|
Copyright©2007 PR Newswire.
All rights reserved